Searched for
SANZYME
5 stocks with 1-year upside price potential up to 33%The companies that generate returns on capital higher than the stakeholders’ expectations are good bets.- Local pharma companies queue up for JB Chemicals & PharmaceuticalsMankind Pharma, Dr Reddy's Laboratories, and Torrent Pharma are interested in acquiring JB Chemicals & Pharmaceuticals from KKR. KKR's inve...
- JB Pharma open to more buys to grow branded biz shareJB Chemicals & Pharmaceuticals (JB Pharma), controlled by US private equity firm KKR, is evaluating assets for acquisitions to strengthen i...
- Fantastic 4 multibagger stocks that have given at least 25% return in last 4 years. Will history repeat?Four consistent performers in the Indian stock market have been identified through a screener search, each having delivered over 25% annual...
- JB Pharma acquires rosuvastatin brand from Glenmark for Rs 314 croreThe acquisition will be funded through long term debt and internal accruals. Razel ranks among the top 10 brands in India in the rosuvastat...
- JB Pharma acquires paediatric brands from Dr Reddy's for Rs 98.3 croreThe four brands are zinc supplement Z&D, insomnia medication Pedicloryl, antibiotic Pecef and Ezinapi, which is used against diaper rashes....
- Buy J B Chemicals & Pharmaceuticals, target price Rs 1896: ICICI SecuritiesJ B Chemicals & Pharmaceuticals Ltd., incorporated in the year 1976, is a Mid Cap company (having a market cap of Rs 12820.33 Crore) operat...
- KKR-backed JBCPL unveils new logo & identity“In 45 years, we at JB have built a strong foundation of integrity, trust and reliability. Now we are taking the next leap forward towards ...
- Indian pharma chases growth with niche home buys, tie-ups as US booster fadesThe US market with its headwinds related to increased competitive intensity, pricing pressures and high regulations, has not remained as lu...
- Torrent Pharma, JB Chemicals in final race to acquire Curatio HealthcareDr Reddy's Laboratories is also understood to have made to the penultimate round of bidding process, people with direct knowledge of the ma...
- JB Chemicals to acquire brands from Sanzyme for Rs 628 croreJB Chemicals and Pharmaceuticals Ltd on Thursday said it will acquire brands for the Indian market from Sanzyme Pvt Ltd, a player in the pr...
- JBCPL to buy probiotic and reproductive brands from Sanzyme for Rs 628 croreThe acquired portfolio includes Sporlac which is the third largest probiotics brand in India and specialized products such as Lobun - a pro...
Load More
